© 1999 European Society of Cardiology
Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative
* Corresponding author: Prof. John G.F. Cleland, Department of Cardiology University of Hull, Castle Hill Hospital, Kingston-upon-Hull, UK
 |
Abstract |
|---|
Background: Previous reports suggest that patients with suspected heart failure are inadequately investigated and that patients who do have heart failure are sub-optimally treated. Guidelines on the diagnosis and treatment of heart failure have been published by the European Society of Cardiology and provide a framework for the management of heart failure against which to judge current medical practice. Both primary care and hospital physicians are responsible for ensuring appropriate management of patients with heart failure. This programme concentrates on management of heart failure in primary care and is complementary to a similar exercise that will be conducted in 50 European regions (EUROHEART-CHF).
Aims: The IMPROVEMENT of HF initiative investigates, in Europe, how primary care physicians perceive heart failure should be diagnosed and treated and whether they perceive that they are provided with adequate support to implement best medical practice. Subsequently, their perceptions are compared to their actual practice by reviewing relevant case notes. The results will be used to recommend changes in practice. A future study is planned to analyse the impact of the initiative.
Methods: The initiative comprises a research phase and an educational phase. For the research phase, 10 regional centres (to include both urban and rural areas) from each of 14 participating countries have been identified and each region has randomly selected 10 primary healthcare physicians. The primary healthcare physicians are participating in two surveys: a ‘perception’ survey and an ‘actual practice’ survey. For the ‘actual practice’ survey, the physicians are supplying case notes of nine patients who have or are at high risk of having heart failure. The results of these surveys will be used to organise an educational programme.
Conclusion: This study is expected to provide valuable data on the perceptions of primary care physicians about heart failure, possible deficiencies in the current provision of care and how any deficiencies may be corrected.
Key Words: Heart failure • Guidelines • Primary care • European Society
Accepted April 2, 1999
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Stork, H. W. Hense, C. Zentgraf, I. Uebelacker, R. Jahns, G. Ertl, and C. E. Angermann Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure A prospective cohort study Eur J Heart Fail, December 1, 2008; 10(12): 1236 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W F B.-A. de la Porte, D. J A Lok, D. J van Veldhuisen, J. van Wijngaarden, J. H Cornel, N. P A Zuithoff, E. Badings, and A. W Hoes Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study Heart, July 1, 2007; 93(7): 819 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Senior To revascularize or not to revascularize: a dilemma in heart failure. Can. Med. Assoc. J., August 15, 2006; 175(4): 372 - 372. [Full Text] [PDF]
|
|
|
|
|
|
H. B. Sturm, F. M. Haaijer-Ruskamp, N. J. Veeger, C. P. Balje-Volkers, K. Swedberg, and W. H. van Gilst The relevance of comorbidities for heart failure treatment in primary care: A European survey Eur J Heart Fail, January 1, 2006; 8(1): 31 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.D. R. Hobbs, J. Korewicki, J. G.F. Cleland, J. Eastaugh, N. Freemantle, and on behalf of the IMPROVEMENT Investigators The diagnosis of heart failure in European primary care: The IMPROVEMENT Programme survey of perception and practice Eur J Heart Fail, August 1, 2005; 7(5): 768 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.F. B.-A. de la Porte, D. J.A. Lok, J. van Wijngaarden, J. H. Cornel, D. Pruijsers-Lamers, D. J. van Veldhuisen, and A. W. Hoes Heart failure programmes in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study Eur J Heart Fail, August 1, 2005; 7(5): 910 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G.F. Cleland, K. Goode, and K. Lalukota Diagnosing heart failure in primary care: lessons from EPICA Eur J Heart Fail, October 1, 2004; 6(6): 793 - 794. [Full Text] [PDF]
|
|
|
|
|
|
A. P. Coletta, A. L. Clark, A.-M. L. Seymour, and J. G.F. Cleland Clinical trials update from the European Society of Cardiology Heart Failure meeting: COMET, COMPANION, Tezosentan and SHAPE Eur J Heart Fail, August 1, 2003; 5(4): 545 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.G.F Cleland, K Swedberg, F Follath, M Komajda, A Cohen-Solal, J.C Aguilar, R Dietz, A Gavazzi, R Hobbs, J Korewicki, et al. The EuroHeart Failure survey programme--a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis Eur. Heart J., March 1, 2003; 24(5): 442 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Pont, W. H. van Gilst, D. J.A. Lok, H. J.A. Kragten, F. M. Haaijer-Ruskamp, and on behalf of the Dutch Working Group on Heart Fail The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice Eur J Heart Fail, March 1, 2003; 5(2): 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.R. Cowie The fine art of prognostication Eur. Heart J., December 1, 2002; 23(23): 1804 - 1806. [Full Text] [PDF]
|
|
|
|
|
|
J. Muntwyler, G. Abetel, C. Gruner, and F. Follath One-year mortality among unselected outpatients with heart failure Eur. Heart J., December 1, 2002; 23(23): 1861 - 1866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J G F Cleland Contemporary management of heart failure in clinical practice Heart, October 1, 2002; 88(90002): ii5 - 8. [Full Text] [PDF]
|
|
|
|
|
|
J.G.F. Cleland, A. Khand, and A. Clark The heart failure epidemic: exactly how big is it? Eur. Heart J., April 2, 2001; 22(8): 623 - 626. [PDF]
|
|
|
|
|
|
K. Witte, S. Thackray, A. L. Clark, M. Cooklin, and J. G.F. Cleland Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART Eur J Heart Fail, December 1, 2000; 2(4): 455 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.G.F. Cleland, K. Swedberg, A. Cohen-Solal, J. Cosin-Aguilar, R. Dietz, F. Follath, A. Gavazzi, R. Hobbs, J. Korewicki, H.C. Madeira, et al. The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe Eur J Heart Fail, June 1, 2000; 2(2): 123 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. McMurray Heart failure: we need more trials in typical patients Eur. Heart J., May 1, 2000; 21(9): 699 - 700. [PDF]
|
|
|
|
|
|
J. Muntwyler and F. Follath Management of heart failure in Switzerland Eur J Heart Fail, March 1, 2000; 2(1): 113 - 114. [Abstract] [Full Text] [PDF]
|
|